Belluscura (LSE:BELL) Other Stockholders Equity: £5.52 Mil (As of Jun. 2024)


What is Belluscura Other Stockholders Equity?

Belluscura LSE:BELL Other Stockholders Equity is £5.52 Mil as of Jun. 2024.

Belluscura's Other Stockholders Equity for the quarter that ended in Jun. 2024 was £5.52 Mil.

Belluscura's quarterly Other Stockholders Equity increased from Jun. 2023 (£2.37 Mil) to Dec. 2023 (£5.39 Mil) and increased from Dec. 2023 (£5.39 Mil) to Jun. 2024 (£5.52 Mil).

Belluscura's annual Other Stockholders Equity declined from Dec. 2021 (£-0.54 Mil) to Dec. 2022 (£-3.73 Mil) but then increased from Dec. 2022 (£-3.73 Mil) to Dec. 2023 (£5.39 Mil).

Belluscura Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Belluscura's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Belluscura Other Stockholders Equity Chart

Belluscura Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial 0.16 0.33 -0.54 -3.73 5.39

Belluscura Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -3.32 -3.73 2.37 5.39 5.52

Belluscura Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of £5.52 Mil mean?
Belluscura (LSE:BELL) has a Other Stockholders Equity of £5.52 Mil as of Jun. 2024. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Belluscura and its competitors.
Is Belluscura's Other Stockholders Equity too high?
Belluscura's current Other Stockholders Equity is £5.52 Mil.
How does Belluscura's Other Stockholders Equity compare to ABT and BSX?
Belluscura's Other Stockholders Equity of £5.52 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Belluscura and its competitors. Belluscura's current Other Stockholders Equity is £5.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Belluscura stock overvalued right now?
Belluscura (LSE:BELL) has a current Other Stockholders Equity of £5.52 Mil. The current Other Stockholders Equity is £5.52 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Belluscura (LSE:BELL), the current Other Stockholders Equity is £5.52 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Belluscura Business Description

Address 15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The company has only one operating segment being the sale of oxygen concentrators in the United States. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.